<h1>Fermenta Biotech Q3FY25: Net Profit Soars 379% YoY, Revenue Up 58%, Driven by Nutrition Segment Growth</h1> Fermenta Biotech Limited reported a significant increase in financial performance for Q3FY25, with a net profit of INR 37.9 crore, marking a 379% year-on-year and 341% quarter-on-quarter rise. The company's revenue reached INR 156.46 crore, up 58% YoY and 65% QoQ, driven by growth in the Human and Animal Nutrition segments. EBITDA for the nine months ended December 2024 was INR 80.78 crore, a 183% increase YoY. The German subsidiary's revenue grew by 383%, and the US subsidiaries saw an 80% increase. Fermenta also repaid its high-interest real estate debt and received industry awards for excellence.